Φορτώνει......
A NOVEL PHARMACOTHERAPY APPROACH USING P-GLYCOPROTEIN (PGP/ABCB1) EFFLUX INHIBITOR COMBINED WITH IVERMECTIN TO REDUCE ALCOHOL DRINKING, PREFERENCE IN MICE
Alcohol Use Disorder (AUD) has a major national impact, affecting over 18 million people, causing approximately 88,000 deaths and costing upward of $220 billion annually in the US. Unfortunately, FDA-approved AUD pharmaceuticals are few, and clinical benefits are mostly ineffective in patients suffe...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Alcohol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7292774/ https://ncbi.nlm.nih.gov/pubmed/32278067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.alcohol.2020.03.013 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|